Expression of INAFM2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

INAFM2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 18.03

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

18.1

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	50.0
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	44.3
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	34.6
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	33.1
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	32.5
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	32.4
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	30.7
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	30.3
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	30.2
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	28.7
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	28.4
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	28.1
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	27.5
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	27.3
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	26.8
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	26.5
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	26.2
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	26.2
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	25.6
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	25.6
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	25.4
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	25.1
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	25.1
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	25.1
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	24.7
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	24.7
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	24.6
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	24.6
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	24.1
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	24.1
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	24.0
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	23.9
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	23.8
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	23.8
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	23.5
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	22.7
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	22.4
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	22.2
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	22.0
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	21.9
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	21.7
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	21.6
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	21.6
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	21.6
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	21.4
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	21.1
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	21.0
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	20.5
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	20.5
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	20.3
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	20.1
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	20.1
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	19.8
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	19.6
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	19.2
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	18.7
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	18.5
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	18.4
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	18.2
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	18.2
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	18.2
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	18.0
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	18.0
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	17.9
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	17.7
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	17.5
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	17.5
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	17.4
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	17.4
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	17.4
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	17.3
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	17.3
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	17.2
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	17.2
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	17.0
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	16.9
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	16.8
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	16.8
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	16.8
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	16.6
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	16.5
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	16.4
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	16.3
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	16.3
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	16.3
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	16.2
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	15.7
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	15.7
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	15.6
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	15.5
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	15.5
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	15.3
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	14.9
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	14.6
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	14.4
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	14.4
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	14.2
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	13.9
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	13.7
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	13.6
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	13.6
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	13.4
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	13.3
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	13.1
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	13.1
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	13.1
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	13.0
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	13.0
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	12.9
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	12.7
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	12.5
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	12.2
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	12.0
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	11.8
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	11.7
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	11.6
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	11.4
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	11.2
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	11.1
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	11.0
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	11.0
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	10.8
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	10.5
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	10.1
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	10.1
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	10.0
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	9.7
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	8.9
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	8.7
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	8.7
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	8.7
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	7.9
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	6.6
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	6.6
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	6.6
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	6.0
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	5.9
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	5.7
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	5.2
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	4.9
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	4.8
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

INAFM2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 30.52

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

27.8

Number of samples

Samples

Sample	Description	TPM
AK005	N, NA, stage:NA, dead, 240 days	96.0
AK030	N, NA, stage:NA, dead, 120 days	93.4
AK188	N, NA, stage:NA, alive, 420 days	50.1
AK066	N, NA, stage:NA, alive, 960 days	43.4
AK071	N, NA, stage:NA, dead, 540 days	37.6
AK124	N, NA, stage:NA, alive, 1920 days	37.2
AK003	N, NA, stage:NA, dead, 600 days	36.6
AK079	N, NA, stage:NA, dead, 210 days	35.7
AK100	N, NA, stage:NA, alive, 960 days	34.9
AK199	N, NA, stage:NA, alive, 1860 days	34.5
AK218	N, NA, stage:NA, dead, 180 days	34.3
AK103	N, NA, stage:NA, alive, 1320 days	34.1
AK133	N, NA, stage:NA, dead, 360 days	34.0
AK076	N, NA, stage:NA, alive, 660 days	33.2
AK098	N, NA, stage:NA, dead, 660 days	31.7
AK139	N, NA, stage:NA, dead, 270 days	29.3
AK088	N, NA, stage:NA, dead, 360 days	29.2
AK195	N, NA, stage:NA, dead, 390 days	29.1
AK236	N, NA, stage:NA, dead, 360 days	28.9
AK216	N, NA, stage:NA, dead, 360 days	28.6
AK074	N, NA, stage:NA, alive, 300 days	28.3
AK091	N, NA, stage:NA, dead, 210 days	27.7
AK173	N, NA, stage:NA, dead, 180 days	27.6
AK149	N, NA, stage:NA, dead, 420 days	27.5
AK099	N, NA, stage:NA, dead, 420 days	26.1
AK134	N, NA, stage:NA, dead, 360 days	25.6
AK035	N, NA, stage:NA, dead, 210 days	25.4
AK231	N, NA, stage:NA, dead, 240 days	25.3
AK183	N, NA, stage:NA, alive, 360 days	24.7
AK081	N, NA, stage:NA, dead, 180 days	23.9
AK226	N, NA, stage:NA, dead, 360 days	23.3
AK213	N, NA, stage:NA, alive, 2010 days	23.1
AK085	N, NA, stage:NA, alive, 660 days	22.8
AK185	N, NA, stage:NA, alive, 330 days	22.6
AK072	N, NA, stage:NA, dead, 150 days	22.5
AK015	N, NA, stage:NA, alive, 720 days	22.2
AK089	N, NA, stage:NA, dead, 330 days	22.1
AK041	N, NA, stage:NA, alive, 810 days	21.6
AK049	N, NA, stage:NA, dead, 180 days	21.5
AK142	N, NA, stage:NA, alive, 90 days	21.4
AK178	N, NA, stage:NA, dead, 240 days	20.8
AK153	N, NA, stage:NA, dead, 240 days	20.4
AK227	N, NA, stage:NA, alive, 300 days	20.2
AK068	N, NA, stage:NA, alive, 360 days	20.0
AK123	N, NA, stage:NA, dead, 180 days	19.8
AK043	N, NA, stage:NA, alive, 660 days	19.5
AK158	N, NA, stage:NA, dead, 360 days	18.6
AK002	N, NA, stage:NA, dead, 570 days	18.4
AK006	N, NA, stage:NA, dead, 360 days	18.4
AK055	N, NA, stage:NA, dead, 240 days	18.2
AK156	N, NA, stage:NA, dead, 330 days	17.6
AK102	N, NA, stage:NA, alive, 1740 days	16.9
AK205	N, NA, stage:NA, dead, 120 days	16.5
AK053	N, NA, stage:NA, dead, 300 days	16.4
AK117	N, NA, stage:NA, dead, 210 days	16.0
AK167	N, NA, stage:NA, dead, 180 days	14.9
AK165	N, NA, stage:NA, alive, 360 days	12.9
AK051	N, NA, stage:NA, dead, 360 days	12.5
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0204390003	Normal	1.4
CPT0205780003	Tumor	1.2
CPT0225760003	Tumor	0.9
CPT0168480003	Tumor	0.8
CPT0190360004	Tumor	0.8
CPT0204410003	Normal	0.8
CPT0087950003	Tumor	0.7
CPT0205450004	Tumor	0.7
CPT0182580003	Tumor	0.6
CPT0171580008	Tumor	0.6
CPT0224600003	Tumor	0.6
CPT0201710003	Tumor	0.6
CPT0218770003	Tumor	0.6
CPT0127480003	Tumor	0.6
CPT0186100003	Tumor	0.5
CPT0168830003	Tumor	0.5
CPT0217190003	Tumor	0.5
CPT0204420003	Normal	0.5
CPT0087680003	Tumor	0.5
CPT0168270003	Tumor	0.5
CPT0204380003	Normal	0.5
CPT0093450003	Tumor	0.5
CPT0218690004	Tumor	0.5
CPT0064890003	Tumor	0.5
CPT0204370003	Normal	0.4
CPT0125510003	Tumor	0.4
CPT0078580003	Tumor	0.4
CPT0162140003	Tumor	0.4
CPT0189850004	Tumor	0.4
CPT0206110003	Tumor	0.4
CPT0167640003	Tumor	0.3
CPT0219080004	Tumor	0.2
CPT0093550003	Tumor	0.2
CPT0002410011	Tumor	0.2
CPT0189570004	Tumor	0.2
CPT0189460003	Tumor	0.2
CPT0217710008	Tumor	0.2
CPT0204330003	Normal	0.2
CPT0217880003	Tumor	0.2
CPT0224390004	Tumor	0.2
CPT0218890004	Tumor	0.2
CPT0205670004	Tumor	0.1
CPT0167970003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0209440003	Tumor	0.1
CPT0206560003	Tumor	0.1
CPT0204350003	Normal	0.1
CPT0208980003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0104330003	Tumor	0.0
CPT0224330003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0206000004	Tumor	0.0
CPT0224540004	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0064650003	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0206670004	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0168720003	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0104220003	Tumor	-0.1
CPT0206230003	Tumor	-0.1
CPT0218330004	Tumor	-0.1
CPT0205890003	Tumor	-0.1
CPT0189750004	Tumor	-0.1
CPT0190240004	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0167750004	Tumor	-0.2
CPT0218830004	Tumor	-0.2
CPT0127420003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0168590003	Tumor	-0.2
CPT0207030003	Tumor	-0.3
CPT0182550003	Tumor	-0.3
CPT0207090003	Tumor	-0.3
CPT0162020003	Tumor	-0.3
CPT0217430008	Tumor	-0.3
CPT0205570003	Tumor	-0.4
CPT0089150003	Tumor	-0.4
CPT0196850003	Tumor	-0.4
CPT0123530003	Tumor	-0.4
CPT0079790003	Tumor	-0.4
CPT0161730003	Tumor	-0.4
CPT0167860004	Tumor	-0.5
CPT0162100003	Tumor	-0.5
CPT0168080003	Tumor	-0.5
CPT0218960004	Tumor	-0.6
CPT0217000004	Tumor	-1.2
CPT0206330003	Tumor	N/A
CPT0216920008	Tumor	N/A
CPT0093590003	Tumor	N/A
CPT0204400003	Normal	N/A
CPT0189650004	Tumor	N/A
CPT0218670003	Tumor	N/A
CPT0204340003	Normal	N/A
CPT0206780003	Tumor	N/A
CPT0182500003	Tumor	N/A
CPT0125220003	Tumor	N/A
CPT0087730003	Tumor	N/A
CPT0087570003	Tumor	N/A
CPT0175060003	Tumor	N/A
CPT0093510003	Tumor	N/A
CPT0228220003	Tumor	N/A
CPT0225730003	Tumor	N/A
CPT0093360003	Tumor	N/A
CPT0206450003	Tumor	N/A
CPT0199770003	Tumor	N/A
CPT0217100003	Tumor	N/A
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis